We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice for medical professionals to follow when assessing drivers with neurological disorders.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine ganaxolone (Ztalmy) as the first anti-seizure medication in the UK to treat cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD).
Information to assist with differentiating Lyme disease from other causes of rash, neurological or non-specific symptoms.
Appendix to the assessing fitness to drive guide for medical professionals.
The characteristics, diagnosis, management, surveillance and epidemiology of CJD.
How to spot equine viral encephalomyelitis, what to do if you suspect it and how to prevent it spreading.
Clinical advice on West Nile virus including symptoms, diagnosis and epidemiology.
Safety leaflet on epilepsy medicines and pregnancy to help patients and their families understanding the risks.
Listing of countries with a known occurrence of high consequence infectious disease (HCID).
Onchocerciasis is an eye and skin disease that causes severe discomfort and can lead to permanent blindness.
Check if you need to tell DVLA about a health or medical condition, how to report medical conditions to DVLA
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
Advice for medical professionals to use when assessing drivers with cardiovascular disorders.
Explains how commissioners and health professionals can use data and analysis for decisions about neurology services and interventions.
Neurocysticercosis causes approximately 30% of epilepsy cases in humans in the developing world
A to Z on content relating to infectious diseases.
You must tell DVLA if you've had any epileptic seizures or blackouts - download the correct form to let them know
Notifications of infectious diseases (NOIDs) and reportable causative organisms: legal duties of laboratories and medical practitioners.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.